...more infoNeurotrophic Bioscience Inc. Signs DiscoverEase(R) Agreement
Neurotrophic Bioscience Inc. (NTB) (a private biotechnology discovery
company) today announced that the company has joined as a participant
in a program providing access to a large, state-of-the-art protein library
with the goal of accelerated identification of trophic factors for
neurodegenerative diseases which may have therapeutic value. As a
participant in the DiscoverEase(R) program created by Genetics Institute
(a unit of Wyeth-Ayerst Laboratories, the pharmaceutical division of
American Home Products Corporation (NYSE:AHP)), NTB will have
access to a novel collection of proprietary human secreted proteins, the
corresponding genes, and a relational database of associated
information. NTB will initially screen 500 such proteins using its
proprietary biological assays and know how, to identify proteins having a
role and function in the survival and development of specific types of
neurons.